Same Indication

Montelukast vs Osimertinib

Montelukast vs Osimertinib: Overview

This comparison examines the pharmacological differences between Montelukast and Osimertinib.

Mechanism of Action

Montelukast: Selective leukotriene D4 receptor antagonist.

Osimertinib: Third-generation irreversible EGFR TKI targeting T790M resistance mutation and activating mutations.

Pharmacokinetics

Half-life: Montelukast — 2.7-5.5 hours; Osimertinib — 48 hours.

Chemical Properties

Molecular Formula: Montelukast — C35H36ClNO3S; Osimertinib — C28H33N7O2.

Molecular Weight: Montelukast — 586.1800 g/mol; Osimertinib — 499.6050 g/mol.

Type: Montelukast — Small molecule; Osimertinib — Small molecule.